Wells Fargo & Company Ginkgo Bioworks Holdings, Inc. Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$0.28 - $1.16 $8,679 - $35,958	-30,999 Reduced 37.83%	50,947 $16,000
Q1 2024 May 10, 2024	BUY	$1.06 - $1.67 $6,914 - $10,893	6,523 Added 8.65%	81,946 $95,000
Q4 2023 Feb 09, 2024	SELL	$1.26 - $1.79 $21,896 - $31,106	-17,378 Reduced 18.73%	75,423 $127,000
Q3 2023 Nov 13, 2023	BUY	$1.61 - $2.54 $9,716 - $15,328	6,035 Added 6.96%	92,801 $167,000
Q2 2023 Aug 15, 2023	BUY	$1.14 - $1.95 $27,302 - $46,702	23,950 Added 38.13%	86,766 $161,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.19 $17,186 - $31,365	14,322 Added 29.53%	62,816 $83,000
Q4 2022 Feb 13, 2023	SELL	$1.63 - $3.52 $6,200 - $13,390	-3,804 Reduced 7.27%	48,494 $81,000
Q3 2022 Nov 14, 2022	BUY	$0.73 - $3.74 $5,208 - $26,684	7,135 Added 15.8%	52,298 $163,000
Q2 2022 Aug 12, 2022	BUY	$2.2 - $4.2 $26,268 - $50,148	11,940 Added 35.94%	45,163 $107,000
Q1 2022 May 16, 2022	SELL	$2.83 - $8.69 $457,011 - $1.4 Million	-161,488 Reduced 82.94%	33,223 $135,000
Q4 2021 Feb 14, 2022	BUY	$8.31 - $14.92 $1.44 Million - $2.58 Million	172,911 Added 793.17%	194,711 $1.62 Million
Q3 2021 Nov 15, 2021	BUY	$9.15 - $13.28 $199,470 - $289,504	21,800 New	21,800 $252,000

48.1M

Ticker DNA
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 1,287,779,968
Market Cap $10.2B
Description
Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.